Eligibility depends on clinical details.
Trial discussions may involve diagnosis, stage, prior treatment, biomarkers, timing, location, and patient preference. Not every study is a fit for every patient.
Research-informed care
Evidence-guided conversations about innovation.
Lumivora Oncology discusses clinical trials as one possible option for eligible patients, alongside standard treatment planning, biomarker testing, and referral opportunities when appropriate.
Testing should be explained clearly.
When molecular or biomarker testing is relevant, the team explains what a result may change, what it may not change, and how it could influence treatment choices.
Some opportunities require referral partners.
When a research option is better served through an academic center or trial network, Lumivora can help patients understand referral pathways and next steps.
What patients can expect
How research conversations are handled.
Careful evaluation
Clinical trials are considered alongside diagnosis, test results, prior treatment, goals of care, and practical factors such as travel, timing, and eligibility requirements.
Clear expectations
Patients receive straightforward explanations about potential benefits, limitations, risks, and whether a referral may be needed to pursue a research option.
Next step
Ready to speak with an oncology care team?
Request an appointment and a Lumivora coordinator will help you prepare the right records and next steps.